NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

全球胰岛素注射液的市场预测、竞争趋势、成长机会 (~2025年):各适应症、品牌、给药途径、类型、作用表现时间、产品、地区

Global Human Insulin Market, By Indication, By Brand, By Route of Administration, By Type, By Onset Time, By Products, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品编码 979731
出版日期 内容资讯 英文 311 Pages
商品交期: 请询问到货日
价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

全球胰岛素注射液的市场预测、竞争趋势、成长机会 (~2025年):各适应症、品牌、给药途径、类型、作用表现时间、产品、地区 Global Human Insulin Market, By Indication, By Brand, By Route of Administration, By Type, By Onset Time, By Products, By Region, Forecast & Opportunities, 2025
出版日期: 2021年01月01日内容资讯: 英文 311 Pages
简介

全球胰岛素注射液的市场规模从2019年的269亿1000万美元,在预测期间中以8.01%的年复合成长率成长。老年人口增加,糖尿病患者的增加,肥胖的盛行率上升,人类胰岛素类似物的需求增加等要素促进该市场的成长。同时,成本效益,偿付价格,胰岛素核准的严格法规等课题妨碍市场进一步成长。

本报告提供全球胰岛素注射液的市场调查,市场定义和概要,新型冠状病毒感染疾病 (COVID-19) 以及其他的市场影响因素分析,世界及各地区、国家的市场规模及市场占有率的变化、预测,各适应症、品牌、产品、给药途径、类型、作用表现时间、产品等各种区分的明细,竞争环境,主要企业简介等资讯汇整。

第1章 产品概要

第2章 调查手法

第3章 COVID-19的影响

第4章 客户的回响

第5章 摘要整理

第6章 全球市场的展望

  • 市场规模、预测
  • 市场占有率、预测
  • 各适应症
    • I型糖尿病
    • II型糖尿病
  • 各品牌
    • Lantus
    • Humulin R
    • Novolin R
    • Humulin N
    • Exubera
    • Afrezza
    • Novolin N
  • 各给药途径
    • 皮下
    • 经鼻
    • 静脉内
    • 经皮
    • 口服
    • 其他
  • 各类型
    • 基础药
    • 大剂量投药
    • 预混合料药
    • 生物相似药
    • 传统
  • 各作用表现时间
    • 速效型
    • 短时间作用型
    • 中间度作用型
    • 长时间作用型
    • 超长时间作用型
    • 事前混合
    • 吸入
  • 各产品
    • 胰岛素笔针
    • 胰岛素帮浦
    • 输液设备
    • 注射
  • 各企业
  • 各地区
  • 市场魅力指数

第7章 北美市场展望

  • 市场规模、预测
  • 市场占有率、预测
  • 各适应症
  • 各品牌
  • 各给药途径
  • 各类型
  • 各作用表现时间
  • 各产品
  • 各国
  • 市场魅力指数
  • 各国分析

第8章 欧洲市场展望

  • 市场规模、预测
  • 市场占有率、预测
  • 各适应症
  • 各品牌
  • 各给药途径
  • 各类型
  • 各作用表现时间
  • 各产品
  • 各国
  • 市场魅力指数
  • 各国分析

第9章 亚太地区市场展望

  • 市场规模、预测
  • 市场占有率、预测
  • 各适应症
  • 各品牌
  • 各给药途径
  • 各类型
  • 各作用表现时间
  • 各产品
  • 各国
  • 市场魅力指数
  • 各国分析

第10章 南美市场展望

  • 市场规模、预测
  • 市场占有率、预测
  • 各适应症
  • 各品牌
  • 各给药途径
  • 各类型
  • 各作用表现时间
  • 各产品
  • 各国
  • 市场魅力指数
  • 各国分析

第11章 中东、非洲市场展望

  • 市场规模、预测
  • 市场占有率、预测
  • 各适应症
  • 各品牌
  • 各给药途径
  • 各类型
  • 各作用表现时间
  • 各产品
  • 各国
  • 市场魅力指数
  • 各国分析

第12章 市场动态

  • 促进因素
  • 课题

第13章 市场趋势

第14章 竞争情形

  • 竞争预测
  • 企业简介
    • Novo Nordisk A/S
    • Sanofi S.A.
    • Eli Lilly and Company
    • Biocon Limited
    • Wockhardt Ltd
    • Nektar Therapeutics
    • Mannkind Corporation
    • A-S Medication Solutions
    • Remedyrepack Inc.
    • Torrent Pharmaceuticals
    • Sedico Co.
    • Gan & Lee Pharmaceuticals
    • BioGenomics Ltd
    • Ypsomed AG
    • Becton, Dickinson and Company
    • B. Braun Melsungen AG
    • Baxter International Inc.,
    • Merck & Co., Inc
    • PerkinElmer
    • Pfizer Inc.

第15章 策略性建议

第16章 关于本公司、免责声明

目录
Product Code: 4637

Title:
Global Human Insulin Market, By Indication (Type I Diabetes, Type II Diabetes), By Brand (Lantus, Humulin R, Novolin R, Humulin N, Exubera, Afrezza, Novolin N), By Route of Administration (Subcutaneous, Transdermal, Nasal, Intravenous, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Pre-Mixed, Inhaled, Ultra-Long Acting), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injections), By Region, Forecast & Opportunities, 2025.

Global human insulin market was valued at USD 26.91 Billion in 2019 is expected to grow at a steady CAGR of 8.01% during the forecast period. Growing geriatric population, increasing diabetic patients, rising prevalence of obesity, and increasing demand for human insulin analogs are contributing to the surging demand for human insulin market, globally. Now a days, diabetes is not only restricted to geriatric population, but it is also common among youth. Also, the technological advancements have eradicated human physical activities leading to obesity and diabetes disorders which is directly influencing the growth of the market. Cost effectiveness, reimbursement prices and strict regulatory requirements for approval of insulin can be considered as a major restraining factor for the market as everyone suffering from diabetes might not be able to afford insulin.

The global human insulin market is segmented on the basis of indication, brand, route of administration, type, onset type, products, and region. Based on indication, market can be bifurcated into type I diabetes and type II diabetes. Type I diabetes is likely to hold the largest market share until 2025 as, human insulin is the most important treatment method for the people suffering from type I diabetes. Based on brand, Lantus segment held the dominant market which is one of the major selling products of Sanofi S.A. As of 2019, subcutaneous segment was the leading segment on the basis of route of administration. This is the most common and preferred route of administration as the insulin is absorbed more quickly. Based on regional analysis, North America dominated the human insulin market in 2019 due to large pool of population suffering from diabetes and presence of leading companies in countries like US and Canada.

Leading players in the global human insulin market include Nektar Therapeutics, MannKind Corporation, Novo Nordisk A/S, Torrent Pharmaceuticals, Inc., Eli Lilly and Company, A-S Medication Solutions, RemedyRepack Inc., Sedico Co., Pharmaceutical Company, Sanofi S.A., Gan & Lee Pharmaceuticals, BioGenomics Ltd., Pfizer Inc., PerkinElmer, Merck & Co., Inc, Biocon Limited, Wockhardt Ltd., Ypsomed AG, Becton Dickinson and Company, B. Braun Melsungen AG, Baxter International Inc., among others.

Years considered for this report:

  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and forecast the market size of global human insulin market.
  • To classify and forecast global human insulin market based on indication, brand, route of administration, type, onset type, products and region.
  • To identify drivers and challenges for global human insulin market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global human insulin market.
  • To conduct pricing analysis for global human insulin market.
  • To identify and analyze the profile of leading players operating in global human insulin market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global human insulin market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Hospitals/clinics, research institutes and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to human insulin
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global human insulin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Indication:

Type I Diabetes

Type II Diabetes

  • Market, By Brand:

Lantus

Humulin R

Novolin R

Humulin N

Exubera

Afrezza

Novolin N

  • Market, By Route of Administration:

Subcutaneous

Nasal

Intravenous

Transdermal

Oral

Others

  • Market, By Type:

Basal

Bolus

Pre-mixed

Biosimilar

Traditional

  • Market, By Onset Time:

Rapid acting

Short-acting

Intermediate acting

Long acting

Ultra-long acting

Pre-mixed

Inhaled

  • Market, By Products:

Insulin Pens

Insulin Pumps

Infusion System

Injection

  • Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore

South America

  • Brazil
  • Argentina
  • Colombia

Middle east & Africa

  • Saudi Arabia
  • South Africa
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global human insulin market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Human Insulin Market

4. Executive Summary

5. Voice of Customer

6. Global Human Insulin Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Indication (Type I Diabetes, Type II Diabetes)
    • 6.2.2. By Brand (Lantus, Humulin R, Novolin R, Humulin N, Exubera, Afrezza, Novolin N)
    • 6.2.3. By Route of administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others)
    • 6.2.4. By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional)
    • 6.2.5. By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled)
    • 6.2.6. By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection)
    • 6.2.7. By Company (2019)
    • 6.2.8. By Region
  • 6.3. Market Attractiveness Index

7. North America Human Insulin Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Indication
    • 7.2.2. By Brand
    • 7.2.3. By Route of Administration
    • 7.2.4. By Type
    • 7.2.5. By Onset Time
    • 7.2.6. By Products
    • 7.2.7. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. North America: Country Analysis
    • 7.4.1. United States Human Insulin Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Indication
        • 7.4.1.2.2. By Brand
        • 7.4.1.2.3. By Route of Administration
        • 7.4.1.2.4. By Type
        • 7.4.1.2.5. By Onset Time
        • 7.4.1.2.6. By Products
    • 7.4.2. Canada Human Insulin Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Indication
        • 7.4.2.2.2. By Brand
        • 7.4.2.2.3. By Route of Administration
        • 7.4.2.2.4. By Type
        • 7.4.2.2.5. By Onset Time
        • 7.4.2.2.6. By Products
    • 7.4.3. Mexico Human Insulin Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Indication
        • 7.4.3.2.2. By Brand
        • 7.4.3.2.3. By Route of Administration
        • 7.4.3.2.4. By Type
        • 7.4.3.2.5. By Onset Time
        • 7.4.3.2.6. By Products

8. Europe Human Insulin Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Indication
    • 8.2.2. By Brand
    • 8.2.3. By Route of Administration
    • 8.2.4. By Type
    • 8.2.5. By Onset Time
    • 8.2.6. By Products
    • 8.2.7. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. Europe: Country Analysis
    • 8.4.1. Germany Human Insulin Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Indication
        • 8.4.1.2.2. By Brand
        • 8.4.1.2.3. By Route of Administration
        • 8.4.1.2.4. By Type
        • 8.4.1.2.5. By Onset Time
        • 8.4.1.2.6. By Products
    • 8.4.2. United Kingdom Human Insulin Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Indication
        • 8.4.2.2.2. By Brand
        • 8.4.2.2.3. By Route of Administration
        • 8.4.2.2.4. By Type
        • 8.4.2.2.5. By Onset Time
        • 8.4.2.2.6. By Products
    • 8.4.3. France Human Insulin Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Indication
        • 8.4.3.2.2. By Brand
        • 8.4.3.2.3. By Route of Administration
        • 8.4.3.2.4. By Type
        • 8.4.3.2.5. By Onset Time
        • 8.4.3.2.6. By Products
    • 8.4.4. Italy Human Insulin Market Outlook
      • 8.4.4.1. Market Size & Forecast
        • 8.4.4.1.1. By Value
      • 8.4.4.2. Market Share & Forecast
        • 8.4.4.2.1. By Indication
        • 8.4.4.2.2. By Brand
        • 8.4.4.2.3. By Route of Administration
        • 8.4.4.2.4. By Type
        • 8.4.4.2.5. By Onset Time
        • 8.4.4.2.6. By Products
    • 8.4.5. Spain Human Insulin Market Outlook
      • 8.4.5.1. Market Size & Forecast
        • 8.4.5.1.1. By Value
      • 8.4.5.2. Market Share & Forecast
        • 8.4.5.2.1. By Indication
        • 8.4.5.2.2. By Brand
        • 8.4.5.2.3. By Route of Administration
        • 8.4.5.2.4. By Type
        • 8.4.5.2.5. By Onset Time
        • 8.4.5.2.6. By Products
    • 8.4.6. Russia Human Insulin Market Outlook
      • 8.4.6.1. Market Size & Forecast
        • 8.4.6.1.1. By Value
      • 8.4.6.2. Market Share & Forecast
        • 8.4.6.2.1. By Indication
        • 8.4.6.2.2. By Brand
        • 8.4.6.2.3. By Route of Administration
        • 8.4.6.2.4. By Type
        • 8.4.6.2.5. By Onset Time
        • 8.4.6.2.6. By Products

9. Asia-Pacific Human Insulin Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Indication
    • 9.2.2. By Brand
    • 9.2.3. By Route of Administration
    • 9.2.4. By Type
    • 9.2.5. By Onset Time
    • 9.2.6. By Products
    • 9.2.7. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. Asia-Pacific: Country Analysis
    • 9.4.1. China Human Insulin Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Indication
        • 9.4.1.2.2. By Brand
        • 9.4.1.2.3. By Route of Administration
        • 9.4.1.2.4. By Type
        • 9.4.1.2.5. By Onset Time
        • 9.4.1.2.6. By Products
    • 9.4.2. India Human Insulin Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Indication
        • 9.4.2.2.2. By Brand
        • 9.4.2.2.3. By Route of Administration
        • 9.4.2.2.4. By Type
        • 9.4.2.2.5. By Onset Time
        • 9.4.2.2.6. By Products
    • 9.4.3. Japan Human Insulin Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Indication
        • 9.4.3.2.2. By Brand
        • 9.4.3.2.3. By Route of Administration
        • 9.4.3.2.4. By Type
        • 9.4.3.2.5. By Onset Time
        • 9.4.3.2.6. By Products
    • 9.4.4. South Korea Human Insulin Market Outlook
      • 9.4.4.1. Market Size & Forecast
        • 9.4.4.1.1. By Value
      • 9.4.4.2. Market Share & Forecast
        • 9.4.4.2.1. By Indication
        • 9.4.4.2.2. By Brand
        • 9.4.4.2.3. By Route of Administration
        • 9.4.4.2.4. By Type
        • 9.4.4.2.5. By Onset Time
        • 9.4.4.2.6. By Products
    • 9.4.5. Australia Human Insulin Market Outlook
      • 9.4.5.1. Market Size & Forecast
        • 9.4.5.1.1. By Value
      • 9.4.5.2. Market Share & Forecast
        • 9.4.5.2.1. By Indication
        • 9.4.5.2.2. By Brand
        • 9.4.5.2.3. By Route of Administration
        • 9.4.5.2.4. By Type
        • 9.4.5.2.5. By Onset Time
        • 9.4.5.2.6. By Products
    • 9.4.6. Singapore Human Insulin Market Outlook
      • 9.4.6.1. Market Size & Forecast
        • 9.4.6.1.1. By Value
      • 9.4.6.2. Market Share & Forecast
        • 9.4.6.2.1. By Indication
        • 9.4.6.2.2. By Brand
        • 9.4.6.2.3. By Route of Administration
        • 9.4.6.2.4. By Type
        • 9.4.6.2.5. By Onset Time
        • 9.4.6.2.6. By Products

10. South America Human Insulin Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Indication
    • 10.2.2. By Brand
    • 10.2.3. By Route of Administration
    • 10.2.4. By Type
    • 10.2.5. By Onset Time
    • 10.2.6. By Products
    • 10.2.7. By Country
  • 10.3. Market Attractiveness Index
  • 10.4. South America: Country Analysis
    • 10.4.1. Brazil Human Insulin Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Indication
        • 10.4.1.2.2. By Brand
        • 10.4.1.2.3. By Route of Administration
        • 10.4.1.2.4. By Type
        • 10.4.1.2.5. By Onset Time
        • 10.4.1.2.6. By Products
    • 10.4.2. Argentina Human Insulin Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Indication
        • 10.4.2.2.2. By Brand
        • 10.4.2.2.3. By Route of Administration
        • 10.4.2.2.4. By Type
        • 10.4.2.2.5. By Onset Time
        • 10.4.2.2.6. By Products
    • 10.4.3. Colombia Human Insulin Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Indication
        • 10.4.3.2.2. By Brand
        • 10.4.3.2.3. By Route of Administration
        • 10.4.3.2.4. By Type
        • 10.4.3.2.5. By Onset Time
        • 10.4.3.2.6. By Products

11. Middle East and Africa Human Insulin Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Indication
    • 11.2.2. By Brand
    • 11.2.3. By Route of Administration
    • 11.2.4. By Type
    • 11.2.5. By Onset Time
    • 11.2.6. By Products
    • 11.2.7. By Country
  • 11.3. Market Attractiveness Index
  • 11.4. MEA: Country Analysis
    • 11.4.1. Saudi Arabia Human Insulin Market Outlook
      • 11.4.1.1. Market Size & Forecast
        • 11.4.1.1.1. By Value
      • 11.4.1.2. Market Share & Forecast
        • 11.4.1.2.1. By Indication
        • 11.4.1.2.2. By Brand
        • 11.4.1.2.3. By Route of Administration
        • 11.4.1.2.4. By Type
        • 11.4.1.2.5. By Onset Time
        • 11.4.1.2.6. By Products
    • 11.4.2. South Africa Human Insulin Market Outlook
      • 11.4.2.1. Market Size & Forecast
        • 11.4.2.1.1. By Value
      • 11.4.2.2. Market Share & Forecast
        • 11.4.2.2.1. By Indication
        • 11.4.2.2.2. By Brand
        • 11.4.2.2.3. By Route of Administration
        • 11.4.2.2.4. By Type
        • 11.4.2.2.5. By Onset Time
        • 11.4.2.2.6. By Products
    • 11.4.3. UAE Human Insulin Market Outlook
      • 11.4.3.1. Market Size & Forecast
        • 11.4.3.1.1. By Value
      • 11.4.3.2. Market Share & Forecast
        • 11.4.3.2.1. By Indication
        • 11.4.3.2.2. By Brand
        • 11.4.3.2.3. By Route of Administration
        • 11.4.3.2.4. By Type
        • 11.4.3.2.5. By Onset Time
        • 11.4.3.2.6. By Products

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Novo Nordisk A/S
    • 14.2.2. Sanofi S.A.
    • 14.2.3. Eli Lilly and Company
    • 14.2.4. Biocon Limited
    • 14.2.5. Wockhardt Ltd
    • 14.2.6. Nektar Therapeutics
    • 14.2.7. Mannkind Corporation
    • 14.2.8. A-S Medication Solutions
    • 14.2.9. Remedyrepack Inc.
    • 14.2.10. Torrent Pharmaceuticals
    • 14.2.11. Sedico Co.
    • 14.2.12. Gan & Lee Pharmaceuticals
    • 14.2.13. BioGenomics Ltd
    • 14.2.14. Ypsomed AG
    • 14.2.15. Becton, Dickinson and Company
    • 14.2.16. B. Braun Melsungen AG
    • 14.2.17. Baxter International Inc.,
    • 14.2.18. Merck & Co., Inc
    • 14.2.19. PerkinElmer
    • 14.2.20. Pfizer Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures

  • Figure 1: Global Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 2: Global Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 3: Global Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 4: Global Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 5: Global Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 6: Global Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 7: Global Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 8: Global Human Insulin Market Share, By Company, By Value, 2019
  • Figure 9: Global Human Insulin Market Share, By Region, By Value, 2015-2025F
  • Figure 10: Global Human Insulin Market Share, By Region, By Value, 2015-2025F
  • Figure 11: Global Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)
  • Figure 12: Global Human Insulin Market Map, By Onset Time, Market Size (USD Billion) & Growth Rate (%)
  • Figure 13: Global Human Insulin Market Map, By Products, Market Size (USD Billion) & Growth Rate (%)
  • Figure 14: Global Human Insulin Market Map, By Region, Market Size (USD Billion) & Growth Rate (%)
  • Figure 15: North America Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 16: North America Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 17: North America Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 18: North America Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 19: North America Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 20: North America Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 21: North America Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 22: North America Human Insulin Market Share, By Country, By Value, 2015-2025F
  • Figure 23: North America Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)
  • Figure 24: United States Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 25: Total Number of Diabetes patients in United States, By Value (Millions), 2019, 2030, 2045
  • Figure 26: United States Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 27: United States Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 28: United States Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 29: United States Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 30: United States Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 31: United States Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 32: Canada Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 33: Total Number of Diabetes patients in Canada, By Value (1000's), 2010, 2019, 2030, 2045
  • Figure 34: Canada Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 35: Canada Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 36: Canada Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 37: Canada Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 38: Canada Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 39: Canada Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 40: Mexico Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 41: Total Number of Diabetes patients in Mexico, By Value (Millions), 2019, 2030, 2045
  • Figure 42: Mexico Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 43: Mexico Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 44: Mexico Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 45: Mexico Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 46: Mexico Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 47: Mexico Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 48: Europe Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 49: Europe Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 50: Europe Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 51: Europe Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 52: Europe Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 53: Europe Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 54: Europe Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 55: Europe Human Insulin Market Share, By Country, By Value, 2015-2025F
  • Figure 56: Europe Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)
  • Figure 57: Germany Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 58: Germany undiagnosed and diagnosed diabetes cases, 2019
  • Figure 59: Germany Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 60: Germany Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 61: Germany Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 62: Germany Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 63: Germany Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 64: Germany Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 65: United Kingdom Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 66: Different types of diabetes in United Kingdom, 2019
  • Figure 67: United Kingdom Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 68: United Kingdom Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 69: United Kingdom Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 70: United Kingdom Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 71: United Kingdom Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 72: United Kingdom Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 73: France Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 74: France Healthcare Spending, By Value (USD Per Capita), 2015-2019
  • Figure 75: France Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 76: France Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 77: France Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 78: France Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 79: France Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 80: France Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 81: Italy Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 82: Total Number of Diabetes patients in Italy, By Value (1000's), 2010, 2019, 2030, 2045
  • Figure 83: Italy Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 84: Italy Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 85: Italy Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 86: Italy Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 87: Italy Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 88: Italy Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 89: Spain Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 90: Total Number of Diabetes patients in Spain, By Value (1000's), 2010, 2019, 2030, 2045
  • Figure 91: Spain Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 92: Spain Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 93: Spain Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 94: Spain Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 95: Spain Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 96: Spain Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 97: Russia Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 98: Total Number of Diabetes patients in Russia, By Value (1000's), 2010, 2019, 2030, 2045
  • Figure 99: Russia Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 100: Russia Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 101: Russia Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 102: Russia Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 103: Russia Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 104: Russia Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 105: Asia-Pacific Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 106: Asia-Pacific Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 107: Asia-Pacific Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 108: Asia-Pacific Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 109: Asia-Pacific Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 110: Asia-Pacific Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 111: Asia-Pacific Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 112: Asia-Pacific Human Insulin Market Share, By Country, By Value, 2015-2025F
  • Figure 113: Asia-Pacific Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)
  • Figure 114: China Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 115: Total Number of Diabetes patients in China, By Value (Millions), 2019, 2030, 2045
  • Figure 116: China Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 117: China Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 118: China Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 119: China Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 120: China Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 121: China Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 122: India Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 123: Total Number of Diabetes patients in India, By Value (Millions), 2019, 2030, 2045
  • Figure 124: India Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 125: India Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 126: India Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 127: India Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 128: India Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 129: India Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 130: Japan Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 131: Japan Total Health Expenditure as a share of GDP, 2015 - 2019
  • Figure 132: Japan Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 133: Japan Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 134: Japan Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 135: Japan Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 136: Japan Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 137: Japan Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 138: South Korea Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 139: Total Number of Diabetes patients in South Korea, By Value (1000's), 2010, 2019, 2030, 2045
  • Figure 140: South Korea Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 141: South Korea Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 142: South Korea Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 143: South Korea Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 144: South Korea Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 145: South Korea Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 146: Australia Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 147: Total Number of Diabetes patients in Australia, By Value (1000's), 2010, 2019, 2030, 2045
  • Figure 148: Australia Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 149: Australia Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 150: Australia Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 151: Australia Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 152: Australia Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 153: Australia Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 154: Singapore Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 155: Total Number of Diabetes patients in Singapore, By Value (1000's), 2010, 2019, 2030, 2045
  • Figure 156: Singapore Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 157: Singapore Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 158: Singapore Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 159: Singapore Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 160: Singapore Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 161: Singapore Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 162: South America Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 163: South America Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 164: South America Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 165: South America Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 166: South America Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 167: South America Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 168: South America Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 169: South America Human Insulin Market Share, By Country, By Value, 2015-2025F
  • Figure 170: South America Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)
  • Figure 171: Brazil Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 172: Total Number of Diabetes patients in Brazil, By Value (Millions), 2019, 2030, 2045
  • Figure 173: Brazil Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 174: Brazil Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 175: Brazil Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 176: Brazil Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 177: Brazil Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 178: Brazil Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 179: Argentina Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 180: Argentina Health Expenditure (% of GDP), 2015-2019
  • Figure 181: Argentina Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 182: Argentina Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 183: Argentina Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 184: Argentina Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 185: Argentina Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 186: Argentina Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 187: Colombia Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 188: Total Number of Diabetes patients in Colombia, By Value (1000's), 2010, 2019, 2030, 2045
  • Figure 189: Colombia Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 190: Colombia Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 191: Colombia Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 192: Colombia Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 193: Colombia Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 194: Colombia Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 195: Middle East and Africa Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 196: Middle East and Africa Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 197: Middle East and Africa Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 198: Middle East and Africa Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 199: Middle East and Africa Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 200: Middle East and Africa Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 201: Middle East and Africa Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 202: Middle East and Africa Human Insulin Market Share, By Country, By Value, 2015-2025F
  • Figure 203: Middle East & Africa Human Insulin Market Map, By Brand, Market Size (USD Billion) & Growth Rate (%)
  • Figure 204: Saudi Arabia Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 205: Total Number of Diabetes patients in Saudi Arabia, By Value (1000's), 2010, 2019, 2030, 2045
  • Figure 206: Saudi Arabia Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 207: Saudi Arabia Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 208: Saudi Arabia Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 209: Saudi Arabia Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 210: Saudi Arabia Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 211: Saudi Arabia Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 212: South Africa Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 213: Total Number of Diabetes patients in South Africa, By Value (1000's), 2010, 2019, 2030, 2045
  • Figure 214: South Africa Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 215: South Africa Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 216: South Africa Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 217: South Africa Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 218: South Africa Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 219: South Africa Human Insulin Market Share, By Products, By Value, 2015-2025F
  • Figure 220: UAE Human Insulin Market Size, By Volume (Million Units), By Value (USD Billion), 2015-2025F
  • Figure 221: UAE Health Expenditure (% of GDP), 2015-2019
  • Figure 222: UAE Human Insulin Market Share, By Indication, By Value, 2015-2025F
  • Figure 223: UAE Human Insulin Market Share, By Brand, By Value, 2015-2025F
  • Figure 224: UAE Human Insulin Market Share, By Route of Administration, By Value, 2015-2025F
  • Figure 225: UAE Human Insulin Market Share, By Type, By Value, 2015-2025F
  • Figure 226: UAE Human Insulin Market Share, By Onset Time, By Value, 2015-2025F
  • Figure 227: UAE Human Insulin Market Share, By Products, By Value, 2015-2025F